Association between predictors of progression of benign prostatic hyperplasia and moderate-to-severe prostatitis-like symptoms: A propensity score–matched analysis-Reference-Cited by-同舟云学术

Association between predictors of progression of benign prostatic hyperplasia and moderate-to-severe prostatitis-like symptoms: A propensity score–matched analysis

Published:2022-06 Issue:2 Volume:10 Page:92-95
ISSN:2287-8882
Container-title:Prostate International
language:en
Short-container-title:Prostate International

Author:

Lee Jun Ho^ORCID,Won Park Yeon,Woo Lee Sin,Duck Choi Jae,Yoon Kang Jung,Yoo Tag Keun

Publisher

Elsevier BV

Subject

Urology

Reference24 articles.

1. The natural history of benign prostatic hyperplasia;Fitzpatrick;BJU Int,2006

2. Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management;Emberton;Int J Clin Pract,2008

3. Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo;Crawford;J Urol,2006

4. Effects of inflammatory prostatitis on the development and progression of benign prostatic hyperplasia: A literature review;Tsunemori;Int J Urol.,2021

5. Relationship between premature ejaculation and chronic prostatitis/chronic pelvic pain syndrome;Lee;J Sex Med,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of extracorporeal shockwave therapy on chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled study;Prostate International;2024-06

2. Investıgatıon of the Relatıonshıp of Two-Glass Test Wıth Prostate Bıopsy and the Presence and Grade of Asymptomatıc Prostate Inflammatıon In Men Wıth Serum Prostate-Specıfıc Antıgen Level Between 2.5-10 Ng/Ml;Konuralp Tıp Dergisi;2024-03-14

3. A prospective, randomized, open‐label, parallel trial comparing the efficacy of α‐blocker or 5α‐reductase inhibitor withdrawal to continued combination therapy on the maintenance of lower urinary tract symptoms in men with benign prostatic hyperplasia;The Prostate;2023-12-27

4. Urological complications after COVID 19 vaccine according to age, sex and manufacturer;World Journal of Urology;2023-07-03

5. Short course of dutasteride in treatment of a refractory category IIIB chronic prostatitis (A placebo-controlled study);Prostate International;2022-12